MEDP Q2 earnings — Revenue +17% YoY · EPS +37% YoY · EBIT -100% YoY · 📈 outlook FY2026: rev $2.8-$2.9B, EPS $17.25-$17.95MEDP Q2 财报 — 营收 +17% YoY · EPS +37% YoY · EBIT -100% YoY · 📈 展望 FY2026: 营收 $2.8-$2.9B, EPS $17.25-$17.95
Core Data
Medpace Holdings, Inc. (MEDP) filed SEC 8-K Item 2.02 at 16:15:39 on July 22, 2026, reporting Q2 2026 results: $707M in revenue, up 17.2% YoY; diluted EPS of $4.25, up 37.1% YoY; EBIT of $0, down 100% YoY. The results beat consensus estimates: EPS consensus was $3.98, revenue consensus was $689.5M.
Operating Leverage Analysis
Q2 2026 revenue grew 17.2% YoY, but EBIT turned negative, marking significant margin compression: quarterly EBIT fell $125M vs. Q2 2025, while revenue only rose $104M YoY. Margin contraction outpaced revenue growth, indicating elevated near-term cost pressures.
Forward Guidance
Exhibit 99.1 to the 8-K included full FY2026 guidance: revenue range $2.81B–$2.88B (midpoint $2.845B) and diluted EPS range $17.25–$17.95 (midpoint $17.60). The guidance midpoint represents ~24.8% of Q2 2026’s single-quarter revenue, implying the remaining three fiscal quarters need to deliver ~$2.138B in combined revenue.
Cross-Reference Signals
Two verified prior signals align with this release: 1) On June 1, 2026, EWALD STEPHEN P, General Counsel & Corporate Secretary, filed a Form 4 disclosing the sale of 16,349 shares at $450/share, for total proceeds of $7,357,050; 2) As of Dec 31, 2025, 81.8% of MEDP’s float was held by 782 institutional investors, a net +96 increase from the prior quarter, with total holdings valued at $24.7B, including 170 new positions, 430 increased positions.
Undisclosed Information and Follow-Up Markers
This filing did not include segment-level revenue breakdowns, core balance sheet metrics, or quarterly order backlog details. Key follow-up items include the upcoming Q2 2026 10-Q filing and the company’s earnings call transcript, which will provide granular cost and order visibility.
核心数据
美迪帕斯控股（MEDP）于2026年7月22日16:15:39提交SEC 8-K表格第2.02项，公布2026年第二季度业绩：营收7.07亿美元，同比增长17.2%；摊薄每股收益4.25美元，同比增长37.1%；息税前利润0美元，同比下滑100%。该业绩超出市场一致预期：市场预期每股收益3.98美元，营收6.895亿美元。
运营杠杆分析
本季度营收同比增长17.2%，但EBIT同比转负，出现显著利润率压缩：季度EBIT较2025年同期减少1.25亿美元，营收同比增量仅1.04亿美元，利润率收缩幅度超过营收增长，反映当期成本压力较大。
未来业绩指引
本次8-K附件99.1披露2026财年全年指引：营收区间28.1亿-28.8亿美元（中值28.45亿美元），每股收益区间17.25-17.95美元（中值17.60美元）。指引中值约为本季度单季营收的24.8%，剩余三季度需合计实现约21.38亿美元营收。
交叉信号验证
结合此前披露的SEC文件与机构持仓数据：1. 2026年6月1日，公司总法律顾问EWALD STEPHEN P通过Form4披露，以450美元/股出售16349股，交易总额735.7万美元；2. 截至2025年12月31日，公司81.8%流通股由782家机构持有，较上一季度增加96家，总持仓市值247亿美元，含170家新进入机构、430家增持机构。
未披露信息与后续关注
本次披露未提供分部门营收明细、资产负债表核心数据及季度订单储备细节。后续需关注公司即将提交的2026年第二季度10-Q表格，以及业绩电话会议披露的成本结构与订单展望。
This analysis was generated by InvestLog AI based on SEC filings, Form 4 insider transactions, Form 144 planned-sale notices, 13F institutional holdings, analyst ratings, and market data. It is for informational purposes only and does not constitute investment advice.这篇研究由 InvestLog AI 基于 SEC 披露、Form 4 内部人交易、Form 144 计划减持、13F 机构持仓、分析师评级和市场数据生成。内容仅供参考，不构成投资建议。